A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/519 (2006.01) A61K 31/437 (2006.01) A61K 31/505 (2006.01) A61K 31/5377 (2006.01) A61K 31/541 (2006.01) A61K 45/06 (2006.01) A61P 3/06 (2006.01) A61P 3/08 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) A61P 9/12 (2006.01)
Patent
CA 2465632
This invention is directed to a method of treating insulin resistance syndrome (IRS), hypertension and/or type 2 diabetes in a mammal comprising administering to said mammal a cGMP PDE9 inhibitor or a pharmaceutical composition thereof. This invention is also directed to such methods wherein said cGMP PDE9 inhibitor is used in combination with other agents to treat IRS, hypertension and/or type 2 diabetes.
Cette invention a trait à une méthode de traitement chez des mammifères du syndrome de la résistance à l'insuline, de l'hypertension et/ou du diabète du type 2, laquelle méthode consiste à administrer un inhibiteur de l'acide guanylique cyclique phosphodiestérase 9 (cGMP PDE9) ou une composition pharmaceutique de celui-ci. L'invention concerne également les méthodes susmentionnées dans le cadre desquelles on utilise cet inhibiteur de cGMP PDE9 associé à d'autres agents pour traiter le syndrome de résistance à l'insuline, l'hypertension et/ou le diabète du type 2.
Fryburg David Albert
Gibbs Earl Michael
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Treatment of insulin resistance syndrome and type 2 diabetes... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of insulin resistance syndrome and type 2 diabetes..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of insulin resistance syndrome and type 2 diabetes... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2059098